Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
A technical investigation has found that specific lots of oxoid legionella bcye growth supplement (sr0110a) may not deliver adequate recovery of legionella pneumophila when used in conjunction with oxoid legionella medium (cm0655) and also with oxoid legionella selective supplement variants. continued use of these lots could result in false negative reporting.